Join the Acne group to help and get support from people like you.
Acne News (Page 2)
Related terms: Acne Vulgaris, Blackheads, Cystic acne, Pimples, Whiteheads, Zits, Breakouts
FDA Approves Cabtreo (clindamycin phosphate, adapalene and benzoyl peroxide) Topical Gel for the Treatment of Acne Vulgaris
LAVAL, Quebec, Oct. 20, 2023 – Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health”) and its dermatology business, Ortho Dermatologics, today announced that the U.S. Food and Drug Admin...
Women With Acne Bear Another Burden: Stigma
THURSDAY, Oct. 12, 2023 – Adult acne can significantly change how women are perceived in social settings, a new study finds. And where the acne is located on the face changes the onlooker’s p...
One Drug Clear Winner in Treating Acne: Review
MONDAY, July 31, 2023 – Millions of people live with acne, and it can take a dramatic toll on their quality of life, but is any one treatment better than the rest? Yes, suggests a new review of more t...
Review: Oral Isotretinoin Is the Best Treatment for Acne
THURSDAY, July 27, 2023 – The most effective treatment for acne is oral isotretinoin, according to a review published in the July/August issue of the Annals of Family Medicine. Chung-Yen Huang,...
FDA Approves Twyneo (tretinoin and benzoyl peroxide) for the Treatment of Acne Vulgaris
NESS ZIONA, Israel, July 27, 2021 (GLOBE NEWSWIRE) – Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a dermatology company focused on identifying, developing and commercializing branded and generic...
FDA Approves Winlevi (clascoterone) Cream for the Treatment of Acne
Lainate, Italy – August 27, 2020 – Cassiopea SpA (SIX: SKIN), today announced that the United States Food and Drug Administration (FDA) approved Winlevi (clascoterone cream 1%) for the treatment of ac...
FDA Approves Arazlo (tazarotene) Lotion for the Topical Treatment of Acne Vulgaris
BRIDGEWATER, N.J., Dec. 19, 2019 /PRNewswire/ – Bausch Health Companies Inc. (NYSE/TSX: BHC) and its dermatology business, Ortho Dermatologics, one of the largest prescription dermatology health...
FDA Approves Amzeeq (minocycline) Topical Foam for the Treatment of Moderate to Severe Acne
REHOVOT, Israel and BRIDGEWATER, N.J., Oct. 18, 2019 (GLOBE NEWSWIRE) – Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX) (“Foamix” or the “Company”), a specialty pharmaceutical company, today announced tha...
FDA Approves Aklief (trifarotene) Cream, a New Topical Retinoid for the Treatment of Acne
FORT WORTH, Texas (October 4, 2019) Galderma, a global leader focused on meeting the world's increasing skin health needs, announced today that the U.S. Food and Drug Administration (FDA) approved...
FDA Approves Seysara (sarecycline) for the Treatment of Moderate to Severe Acne
Barcelona - 2nd October 2018 – Almirall, S.A. announced today that the Food and Drug Administration (FDA) has approved Seysara (sarecycline), a new, innovative first in class tetracycline-derived...
FDA Approves Seysara (sarecycline) for the Treatment of Moderate to Severe Acne
Barcelona - 2nd October 2018 – Almirall, S.A. announced today that the Food and Drug Administration (FDA) has approved Seysara (sarecycline), a new, innovative first in class tetracycline-derived...
Ortho Dermatologics Receives FDA Approval for Altreno (tretinoin 0.05%) Lotion For Acne
LAVAL, Quebec, Aug. 24, 2018 /PRNewswire/ – Ortho Dermatologics, one of the largest prescription dermatology health care businesses in the world and a division of Bausch Health Companies Inc....
FDA Approves Differin Gel 0.1% for Over-the-Counter Use to Treat Acne
July 8, 2016 – The U.S. Food and Drug Administration today approved Differin Gel 0.1% (adapalene), a once-daily topical gel for the over-the-counter (OTC) treatment of acne. Differin Gel 0.1% is...
Allergan Announces FDA Approval of Aczone (dapsone) Gel, 7.5% for Treatment of Acne Vulgaris
DUBLIN, Feb. 25, 2016 /PRNewswire/ – Allergan plc (NYSE:AGN), a leading global pharmaceutical company, today announced that the Company has received approval from the U.S. Food and Drug...
Galderma Receives FDA Approval for Epiduo Forte (adapalene and benzoyl peroxide) for Acne
FT. WORTH, Texas – July 16, 2015 -Galderma Laboratories, L.P. announced today that the U.S. Food and Drug Administration (FDA) approved antibiotic-free Epiduo Forte (adapalene and benzoyl peroxide) G...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Rosacea, Dermatological Disorders
Related drug support groups
doxycycline, cephalexin, Keflex, spironolactone, Accutane, sulfur, sulfamethoxazole / trimethoprim, Yasmin, Milk of Magnesia, isotretinoin, tetracycline, Retin-A